New Treatment Options in Allergic Rhinitis: Patient Considerations and the Role of Ciclesonide

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2008 Aug 30

PMID 18728855

Citations 1

Authors

F Braido

C Lagasio

Img Piroddi

I Baiardini

Gw Canonica

Affiliations

Soon will be listed here.

Abstract

Allergic rhinitis (AR) is a chronic inflammatory respiratory disease affecting 5%-50% of the worldwide population and its prevalence is increasing (Herman 2007). In addition, AR is associated with asthma and other co-morbidities such as conjunctivitis and sinusitis. The main symptoms are nasal congestion, rhinorrea, sneezing, itching, and post-nasal drainage induced after allergen exposure by an IgE-mediated inflammation of the membranes lining the nose. AR is not a life-threatening disease, but it has been shown to have a significant impact on quality of life. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines propose a classification of AR in intermittent and persistent, each graded as mild or moderate-severe, and provide a stepwise approach to the treatment. Inhaled steroids and antihistamine are the main tools in AR therapy but more safe and effective drugs are, however, needed. Inhaled steroid ciclesonide appears to be safe and effective.

Citing Articles

Effect of Biospray Dressings on Eosinophil Infiltration in the Nasal Mucosa and Serum IgE Levels After Nasal Provocation in Experimental Allergic Rhinitis.

Huang S, Wu G, Gu X, Zhu H, Ma X, Yuan Y Allergy Rhinol (Providence). 2020; 11:2152656720902142.

PMID: 32201632 PMC: 7066584. DOI: 10.1177/2152656720902142.

References

Berkowitz R, Roberson S, Zora J, Capano D, Chen R, Lutz C . Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy Asthma Proc. 1999; 20(3):167-72. DOI: 10.2500/108854199778553037. View

Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R . Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol. 1996; 98(2):274-82. DOI: 10.1016/s0091-6749(96)70150-1. View

Meltzer E, Kunjibettu S, Hall N, Wingertzahn M, Murcia C, Berger W . Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007; 98(2):175-81. DOI: 10.1016/s1081-1206(10)60693-x. View

Funder J . Mineralocorticoids, glucocorticoids, receptors and response elements. Science. 1993; 259(5098):1132-3. DOI: 10.1126/science.8382375. View

Plewako H, Arvidsson M, Petruson K, Oancea I, Holmberg K, Adelroth E . The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol. 2002; 110(1):68-71. DOI: 10.1067/mai.2002.125488. View

Laforce C, Dockhorn R, Findlay S, Meltzer E, Nathan R, Stricker W . Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract. 1994; 38(2):145-52. View

Ratner P, Wingertzahn M, van Bavel J, Hampel F, Darken P, Hellbardt S . Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006; 97(5):657-63. DOI: 10.1016/S1081-1206(10)61097-6. View

Kaliner M . Omalizumab and the treatment of allergic rhinitis. Curr Allergy Asthma Rep. 2004; 4(3):237-44. DOI: 10.1007/s11882-004-0032-2. View

Bernstein I . Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. J Allergy Clin Immunol. 2000; 105(1 Pt 1):39-44. DOI: 10.1016/s0091-6749(00)90175-1. View

10.

van Schayck C, van den Broek P, den Otter J, van Herwaarden C, Molema J, van Weel C . Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?. JAMA. 1995; 274(2):161-4. DOI: 10.1001/jama.274.2.161. View

11.

Selroos O, Halme M . Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax. 1991; 46(12):891-4. PMC: 463494. DOI: 10.1136/thx.46.12.891. View

12.

Nave R, Wingertzahn M, Brookman S, Kaida S, Matsunaga T . Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis. J Clin Pharmacol. 2006; 46(4):461-7. DOI: 10.1177/0091270006286437. View

13.

Day J, Briscoe M, Rafeiro E, Ellis A, Pettersson E, AKERLUND A . Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol. 2000; 105(3):489-94. DOI: 10.1067/mai.2000.104550. View

14.

Ukena D . [Ciclesonide -- a new inhaled corticosteroid]. Pneumologie. 2005; 59(10):689-95. DOI: 10.1055/s-2005-915570. View

15.

Pedersen S, Frost L, Arnfred T . Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy. 1986; 41(2):118-24. DOI: 10.1111/j.1398-9995.1986.tb00287.x. View

16.

Gerth van Wijk R . Quality of life, should we bother?. Allergy. 2003; 58(4):284-6. DOI: 10.1034/j.1398-9995.2003.00108.x. View

17.

Passalacqua G, Albano M, Canonica G, Bachert C, Van Cauwenberge P, Davies R . Inhaled and nasal corticosteroids: safety aspects. Allergy. 2000; 55(1):16-33. DOI: 10.1034/j.1398-9995.2000.00370.x. View

18.

Andersson M, Svensson C, Persson C, AKERLUND A, Greiff L . Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol. 2000; 85(4):279-83. DOI: 10.1016/S1081-1206(10)62530-6. View

19.

Nave R, Meyer W, Fuhst R, Zech K . Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide. Pulm Pharmacol Ther. 2005; 18(6):390-6. DOI: 10.1016/j.pupt.2005.02.012. View

20.

Nathan R, Bronsky E, Fireman P, Grossman J, Laforce C, Lemanske Jr R . Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy. 1991; 67(3):332-8. View